IBDEI36H ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,50745,1,4,0)
;;=4^D47.9
;;^UTILITY(U,$J,358.3,50745,2)
;;=^5002260
;;^UTILITY(U,$J,358.3,50746,0)
;;=D53.9^^193^2497^181
;;^UTILITY(U,$J,358.3,50746,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50746,1,3,0)
;;=3^Nutritional Anemia,Unspec
;;^UTILITY(U,$J,358.3,50746,1,4,0)
;;=4^D53.9
;;^UTILITY(U,$J,358.3,50746,2)
;;=^5002298
;;^UTILITY(U,$J,358.3,50747,0)
;;=D47.4^^193^2497^182
;;^UTILITY(U,$J,358.3,50747,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50747,1,3,0)
;;=3^Osteomyelofibrosis
;;^UTILITY(U,$J,358.3,50747,1,4,0)
;;=4^D47.4
;;^UTILITY(U,$J,358.3,50747,2)
;;=^5002259
;;^UTILITY(U,$J,358.3,50748,0)
;;=D59.1^^193^2497^29
;;^UTILITY(U,$J,358.3,50748,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50748,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Other
;;^UTILITY(U,$J,358.3,50748,1,4,0)
;;=4^D59.1
;;^UTILITY(U,$J,358.3,50748,2)
;;=^5002324
;;^UTILITY(U,$J,358.3,50749,0)
;;=D51.3^^193^2497^196
;;^UTILITY(U,$J,358.3,50749,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50749,1,3,0)
;;=3^Vitamin B12 Deficiency Anemia,Other
;;^UTILITY(U,$J,358.3,50749,1,4,0)
;;=4^D51.3
;;^UTILITY(U,$J,358.3,50749,2)
;;=^5002287
;;^UTILITY(U,$J,358.3,50750,0)
;;=D77.^^193^2497^58
;;^UTILITY(U,$J,358.3,50750,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50750,1,3,0)
;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
;;^UTILITY(U,$J,358.3,50750,1,4,0)
;;=4^D77.
;;^UTILITY(U,$J,358.3,50750,2)
;;=^5002396
;;^UTILITY(U,$J,358.3,50751,0)
;;=D58.2^^193^2497^84
;;^UTILITY(U,$J,358.3,50751,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50751,1,3,0)
;;=3^Hemoglobinopathies,Other
;;^UTILITY(U,$J,358.3,50751,1,4,0)
;;=4^D58.2
;;^UTILITY(U,$J,358.3,50751,2)
;;=^87629
;;^UTILITY(U,$J,358.3,50752,0)
;;=C88.8^^193^2497^106
;;^UTILITY(U,$J,358.3,50752,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50752,1,3,0)
;;=3^Malig Immunoproliferative Diseases,Other
;;^UTILITY(U,$J,358.3,50752,1,4,0)
;;=4^C88.8
;;^UTILITY(U,$J,358.3,50752,2)
;;=^5001750
;;^UTILITY(U,$J,358.3,50753,0)
;;=D70.8^^193^2497^179
;;^UTILITY(U,$J,358.3,50753,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50753,1,3,0)
;;=3^Neutropenia,Other
;;^UTILITY(U,$J,358.3,50753,1,4,0)
;;=4^D70.8
;;^UTILITY(U,$J,358.3,50753,2)
;;=^334042
;;^UTILITY(U,$J,358.3,50754,0)
;;=D59.4^^193^2497^180
;;^UTILITY(U,$J,358.3,50754,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50754,1,3,0)
;;=3^Nonautoimmune Hemolytic Anemias,Other
;;^UTILITY(U,$J,358.3,50754,1,4,0)
;;=4^D59.4
;;^UTILITY(U,$J,358.3,50754,2)
;;=^5002326
;;^UTILITY(U,$J,358.3,50755,0)
;;=D69.59^^193^2497^186
;;^UTILITY(U,$J,358.3,50755,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50755,1,3,0)
;;=3^Secondary Thrombocytopenia,Other
;;^UTILITY(U,$J,358.3,50755,1,4,0)
;;=4^D69.59
;;^UTILITY(U,$J,358.3,50755,2)
;;=^5002369
;;^UTILITY(U,$J,358.3,50756,0)
;;=C22.7^^193^2497^47
;;^UTILITY(U,$J,358.3,50756,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50756,1,3,0)
;;=3^Carcinomas of Liver,Other Spec
;;^UTILITY(U,$J,358.3,50756,1,4,0)
;;=4^C22.7
;;^UTILITY(U,$J,358.3,50756,2)
;;=^5000938
;;^UTILITY(U,$J,358.3,50757,0)
;;=D75.89^^193^2497^57
;;^UTILITY(U,$J,358.3,50757,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50757,1,3,0)
;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
;;^UTILITY(U,$J,358.3,50757,1,4,0)
;;=4^D75.89
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI36H 3765 printed Apr 09, 2024@21:15:39 Page 2
IBDEI36H ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,50745,1,4,0)
+2 ;;=4^D47.9
+3 ;;^UTILITY(U,$J,358.3,50745,2)
+4 ;;=^5002260
+5 ;;^UTILITY(U,$J,358.3,50746,0)
+6 ;;=D53.9^^193^2497^181
+7 ;;^UTILITY(U,$J,358.3,50746,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,50746,1,3,0)
+10 ;;=3^Nutritional Anemia,Unspec
+11 ;;^UTILITY(U,$J,358.3,50746,1,4,0)
+12 ;;=4^D53.9
+13 ;;^UTILITY(U,$J,358.3,50746,2)
+14 ;;=^5002298
+15 ;;^UTILITY(U,$J,358.3,50747,0)
+16 ;;=D47.4^^193^2497^182
+17 ;;^UTILITY(U,$J,358.3,50747,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,50747,1,3,0)
+20 ;;=3^Osteomyelofibrosis
+21 ;;^UTILITY(U,$J,358.3,50747,1,4,0)
+22 ;;=4^D47.4
+23 ;;^UTILITY(U,$J,358.3,50747,2)
+24 ;;=^5002259
+25 ;;^UTILITY(U,$J,358.3,50748,0)
+26 ;;=D59.1^^193^2497^29
+27 ;;^UTILITY(U,$J,358.3,50748,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,50748,1,3,0)
+30 ;;=3^Autoimmune Hemolytic Anemia,Other
+31 ;;^UTILITY(U,$J,358.3,50748,1,4,0)
+32 ;;=4^D59.1
+33 ;;^UTILITY(U,$J,358.3,50748,2)
+34 ;;=^5002324
+35 ;;^UTILITY(U,$J,358.3,50749,0)
+36 ;;=D51.3^^193^2497^196
+37 ;;^UTILITY(U,$J,358.3,50749,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,50749,1,3,0)
+40 ;;=3^Vitamin B12 Deficiency Anemia,Other
+41 ;;^UTILITY(U,$J,358.3,50749,1,4,0)
+42 ;;=4^D51.3
+43 ;;^UTILITY(U,$J,358.3,50749,2)
+44 ;;=^5002287
+45 ;;^UTILITY(U,$J,358.3,50750,0)
+46 ;;=D77.^^193^2497^58
+47 ;;^UTILITY(U,$J,358.3,50750,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,50750,1,3,0)
+50 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
+51 ;;^UTILITY(U,$J,358.3,50750,1,4,0)
+52 ;;=4^D77.
+53 ;;^UTILITY(U,$J,358.3,50750,2)
+54 ;;=^5002396
+55 ;;^UTILITY(U,$J,358.3,50751,0)
+56 ;;=D58.2^^193^2497^84
+57 ;;^UTILITY(U,$J,358.3,50751,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,50751,1,3,0)
+60 ;;=3^Hemoglobinopathies,Other
+61 ;;^UTILITY(U,$J,358.3,50751,1,4,0)
+62 ;;=4^D58.2
+63 ;;^UTILITY(U,$J,358.3,50751,2)
+64 ;;=^87629
+65 ;;^UTILITY(U,$J,358.3,50752,0)
+66 ;;=C88.8^^193^2497^106
+67 ;;^UTILITY(U,$J,358.3,50752,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,50752,1,3,0)
+70 ;;=3^Malig Immunoproliferative Diseases,Other
+71 ;;^UTILITY(U,$J,358.3,50752,1,4,0)
+72 ;;=4^C88.8
+73 ;;^UTILITY(U,$J,358.3,50752,2)
+74 ;;=^5001750
+75 ;;^UTILITY(U,$J,358.3,50753,0)
+76 ;;=D70.8^^193^2497^179
+77 ;;^UTILITY(U,$J,358.3,50753,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,50753,1,3,0)
+80 ;;=3^Neutropenia,Other
+81 ;;^UTILITY(U,$J,358.3,50753,1,4,0)
+82 ;;=4^D70.8
+83 ;;^UTILITY(U,$J,358.3,50753,2)
+84 ;;=^334042
+85 ;;^UTILITY(U,$J,358.3,50754,0)
+86 ;;=D59.4^^193^2497^180
+87 ;;^UTILITY(U,$J,358.3,50754,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,50754,1,3,0)
+90 ;;=3^Nonautoimmune Hemolytic Anemias,Other
+91 ;;^UTILITY(U,$J,358.3,50754,1,4,0)
+92 ;;=4^D59.4
+93 ;;^UTILITY(U,$J,358.3,50754,2)
+94 ;;=^5002326
+95 ;;^UTILITY(U,$J,358.3,50755,0)
+96 ;;=D69.59^^193^2497^186
+97 ;;^UTILITY(U,$J,358.3,50755,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,50755,1,3,0)
+100 ;;=3^Secondary Thrombocytopenia,Other
+101 ;;^UTILITY(U,$J,358.3,50755,1,4,0)
+102 ;;=4^D69.59
+103 ;;^UTILITY(U,$J,358.3,50755,2)
+104 ;;=^5002369
+105 ;;^UTILITY(U,$J,358.3,50756,0)
+106 ;;=C22.7^^193^2497^47
+107 ;;^UTILITY(U,$J,358.3,50756,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,50756,1,3,0)
+110 ;;=3^Carcinomas of Liver,Other Spec
+111 ;;^UTILITY(U,$J,358.3,50756,1,4,0)
+112 ;;=4^C22.7
+113 ;;^UTILITY(U,$J,358.3,50756,2)
+114 ;;=^5000938
+115 ;;^UTILITY(U,$J,358.3,50757,0)
+116 ;;=D75.89^^193^2497^57
+117 ;;^UTILITY(U,$J,358.3,50757,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,50757,1,3,0)
+120 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
+121 ;;^UTILITY(U,$J,358.3,50757,1,4,0)
+122 ;;=4^D75.89
